ECSP055871A - TETRAHYDROQUINOLINE DERIVATIVES - Google Patents

TETRAHYDROQUINOLINE DERIVATIVES

Info

Publication number
ECSP055871A
ECSP055871A EC2005005871A ECSP055871A ECSP055871A EC SP055871 A ECSP055871 A EC SP055871A EC 2005005871 A EC2005005871 A EC 2005005871A EC SP055871 A ECSP055871 A EC SP055871A EC SP055871 A ECSP055871 A EC SP055871A
Authority
EC
Ecuador
Prior art keywords
alkoxy
alkylamino
derivatives
heterocycloalkyl
heteroaryl
Prior art date
Application number
EC2005005871A
Other languages
Spanish (es)
Inventor
Cornelis Marius Timmers
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP055871A publication Critical patent/ECSP055871A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de tetrahidroquinolina de la fórmula general (I) o a su sal farmacéuticamente aceptable, en donde R1 y R2 son H o Me; R3 es H, hidroxi, (1-4C)alcoxi, (di)(1-4C)alquilamino(2-4C)alcoxi o (2-6)heterocicloalquil(2-4C)alcoxi; R4 es H, OH, (1-4C)alcoxi o R7; R5 es H, OH, (1-4C)alcoxi o R7, con la condición de que si R4 es H, R5 no es H, OH o (1-4C)alcoxi y si R5 es H, R4 no es H, OH o (1-4C)alcoxi; R6 es (2-5C)heteroarilo, (6C)arilo, (3-8)cicloalquilo, (2-6C)heterocicloalquilo o (1-6C)alquilo; R7 es amino, (di)(1-4C)alquilamino, (6C)arilcarbonilamino, (6C)arilcarboniloxi, (2-5C)heteroarilcarbonilamino, (2-5C)heteroarilcarboniloxi, R8-(2-4C)alquilamino, R8-(2-4C)alcoxi, R9-metilamino o R9-metoxi; R8 es hidroxi, amino, (1-4C)alcoxi, (di)(1-4C)alquilamino, (2-6C)heterocicloalquilo, (2-6C)heterocicloalquilcarbonilamino, (di)(1-4C)alquilaminocarbonilamino o (1-4C)alcoxicarbonilamino y R9 es aminocarbonilo, (di)(1-4C)alquilaminocarbonilo, (2-5C)heteroarilo o (6C)arilo. La presente invención también se refiere a composiciones farmacéuticas que comprenden dichos derivados y al uso de estos derivados para regular la fertilidad.The present invention relates to tetrahydroquinoline derivatives of the general formula (I) or their pharmaceutically acceptable salt, wherein R1 and R2 are H or Me; R3 is H, hydroxy, (1-4C) alkoxy, (di) (1-4C) alkylamino (2-4C) alkoxy or (2-6) heterocycloalkyl (2-4C) alkoxy; R4 is H, OH, (1-4C) alkoxy or R7; R5 is H, OH, (1-4C) alkoxy or R7, with the proviso that if R4 is H, R5 is not H, OH or (1-4C) alkoxy and if R5 is H, R4 is not H, OH or (1-4C) alkoxy; R6 is (2-5C) heteroaryl, (6C) aryl, (3-8) cycloalkyl, (2-6C) heterocycloalkyl or (1-6C) alkyl; R7 is amino, (di) (1-4C) alkylamino, (6C) arylcarbonylamino, (6C) arylcarbonyloxy, (2-5C) heteroarylcarbonylamino, (2-5C) heteroarylcarbonyloxy, R8- (2-4C) alkylamino, R8- ( 2-4C) alkoxy, R9-methylamino or R9-methoxy; R8 is hydroxy, amino, (1-4C) alkoxy, (di) (1-4C) alkylamino, (2-6C) heterocycloalkyl, (2-6C) heterocycloalkylcarbonylamino, (di) (1-4C) alkylaminocarbonylamino or (1- 4C) alkoxycarbonylamino and R9 is aminocarbonyl, (di) (1-4C) alkylaminocarbonyl, (2-5C) heteroaryl or (6C) aryl. The present invention also relates to pharmaceutical compositions comprising said derivatives and the use of these derivatives to regulate fertility.

EC2005005871A 2002-12-20 2005-06-20 TETRAHYDROQUINOLINE DERIVATIVES ECSP055871A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43504002P 2002-12-20 2002-12-20
EP02102866 2002-12-20

Publications (1)

Publication Number Publication Date
ECSP055871A true ECSP055871A (en) 2005-09-20

Family

ID=32683821

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005871A ECSP055871A (en) 2002-12-20 2005-06-20 TETRAHYDROQUINOLINE DERIVATIVES

Country Status (9)

Country Link
KR (1) KR20050084341A (en)
CO (1) CO5590903A2 (en)
DE (1) DE60326390D1 (en)
EC (1) ECSP055871A (en)
EG (1) EG24958A (en)
HR (1) HRP20050576A2 (en)
IS (1) IS2647B (en)
MX (1) MXPA05006767A (en)
NO (1) NO330612B1 (en)

Also Published As

Publication number Publication date
MXPA05006767A (en) 2005-09-08
IS2647B (en) 2010-08-15
NO20052727D0 (en) 2005-06-07
DE60326390D1 (en) 2009-04-09
NO20052727L (en) 2005-07-13
CO5590903A2 (en) 2005-12-30
KR20050084341A (en) 2005-08-26
EG24958A (en) 2011-02-28
HRP20050576A2 (en) 2005-10-31
NO330612B1 (en) 2011-05-30
HK1077577A1 (en) 2006-02-17
IS7871A (en) 2005-05-26

Similar Documents

Publication Publication Date Title
UA81442C2 (en) Tetrahydroquinoline derivatives
ECSP034932A (en) TETRAHYDROQUINOLINE DERIVATIVES
AR034390A1 (en) DERIVATIVES OF 1-SULFONIL-TETRAHIDRO REPLACED KINOLINES, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES AS INHIBITORS OF THE SECRET RANGE
ES2722409T3 (en) ROR gamma modulators (RORy)
UA92083C2 (en) Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
WO2004056779A3 (en) Tetrahydroquinoline derivatives and their use as fsh receptor modulators
ME00555A (en) Tryasolyl tropane derivatives as ccr5 modulators
TW200738706A (en) Pyrido-, pyrazo-and pyrimido-pyrimidine derivatives and their use as mTOR inhibitors
EA200970478A1 (en) TIOPHENE ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
HUP0302526A2 (en) Macrolide compounds, process for their preparation, their use and pharmaceutical compositions containing them
AR061008A1 (en) INDOLOBENZAZEPINE HCV INHIBITORS FUSIONATED TO CYCLOPROPYL
YU18999A (en) Substituted tricyclics
CR7950A (en) SYNTHESIS OF CHLORINE 4AMINO -2BUTENOIL AND ITS USE IN THE PREPARATION OF 3- CIANOQUINOLINES
MXPA04002423A (en) PIPERAZINE DERIVATIVES WITH ANTAGONIST ACTIVITY OF THE RECEIVER CCR1.
BR0009558A (en) Heteroaromatic bicyclic derivative compound, pharmaceutical composition, and use of heteroaromatic bicyclic derivative compounds
AR042346A1 (en) LOW IRRITANT AND HIGH EFFECTIVE ALUMINUM SALTS AND THE ANTI-TRANSPIRING COMPOSITIONS CONTAINING THEM
AR036327A1 (en) COMPOUNDS DERIVED FROM THE CHROMAN FOR THERAPEUTIC USE, PHARMACEUTICAL COMPOSITION, USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES TO TREAT MIGRANTS, RELATED COMPOUNDS, AND PROCESSES TO PREPARE THOSE RELATED COMPOUNDS
AR043487A1 (en) FUSIONED HEREROCICLES OF PYRIMIDINE AND USES OF THE SAME
AR036301A1 (en) ANTI-DIABETIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, PROCEDURE FOR THE PREPARATION OF THESE AND TREATMENT USING THE SAME
AR046753A1 (en) BENZOXAZINE DERIVATIVES AND USES OF THE SAME
AR039319A1 (en) IMIDAZOLINILMETIL ARALQUILSULFONAMIDAS
ECSP055871A (en) TETRAHYDROQUINOLINE DERIVATIVES
MX2021005892A (en) NOVEL ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE AND INHIBITORS OF PHOSPHODIESTERASE WITH DUAL MODE OF ACTION AND THEIR USES.
MY144609A (en) 2-methyl-4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives
AR069700A1 (en) DERIVATIVES OF AZETIDINE, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PREPARATION METHOD, SYNTHESIS INTERMEDIARIES, AND USES OF THE SAME IN THE TREATMENT OR PREVENTION OF PSYCHIATRIC DISORDERS, OF THE IMMUNE SYSTEM AND ENTREPRESTINAL GASTROINTESTINAL SYSTEMS.